SAFETY AND EFFICACY OF LONG-TERM TREATMENT WITH LIRENTELIMAB, A MONOCLONAL ANTIBODY AGAINST SIGLEC-8, IN PATIENTS WITH EOSINOPHILIC GASTRITIS/DUODENITIS

Evan S. Dellon  1     Kathryn Peterson  2     Nirmala Gonsalves  3     Robert Genta  4     John Leung  5     Paneez Khoury  6     Amy Klion  6     Sabine Hazan  7     Adam Bledsoe  8     Sandy Durrani  9     Chao Wang  10     Camilla Shaw  11     Alan Chang  11     BHUPINDER SINGH  11     Amol Kamboj  11     Henrik Rasmussen  11     Ikuo Hirano  11     Mirna Chehade  12     Joseph Murray  12     Gary W. Falk  13     Michael F. Vaezi  14     Marc E. Rothenberg  14    
1 University of North Carolina, Chapel Hill, United States
2 University of Utah, Salt Lake City, United States
3 Northwestern University, Chicago, United States
4 Baylor College of Medicine, Houston, United States
5 Tufts University, Boston, United States
6 NIAID/NIH, Bethesda, United States
7 Ventura Clinical Trials, Ventura, United States
8 Mayo Clinic Rochester, Rochester, United States
9 Cincinnati Children’s Hospital, University of Cincinnati College of Medicine, Cincinnati, United States
10 Pharma Data Associates, Piscataway, United States
11 Allakos, Inc., Redwood City, United States
12 Icahn School of Medicine at Mount Sinai, New York, United States
13 University of Pennsylvania Perelman School of Medicine, Philadelphia, United States
14 Vanderbilt University, Nashville, United States

Topic
Immunology, Oesophagus, Paediatrics

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing